Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia
Wandi Wang, Xiaofang Wu, Jiamian Zheng, Ran Yin, Yangqiu Li, Xiuli Wu, Ling Xu, Zhenyi Jin · 2024
Read Utilizing exosomes as sparking clinical biomarkers and therapeutic response in acute myeloid leukemia by Wandi Wang, Xiaofang Wu, Jiamian Zheng, Ran Yin, Yangqiu Li, Xiuli Wu, Ling Xu, Zhenyi Jin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10824954.txt.
Description
Wandi Wang and co-authors review how tiny cell-made parcels called exosomes shape acute myeloid leukemia, in this 2023 paper. The leukemia grows fast and relapses often, so new angles matter. Exosomes ferry signals between cells and turn up everywhere in this disease. They nudge leukemia cells, healthy blood cells, the marrow environment, and immune escape alike.
Because exosomes carry telling cargo, they may serve as markers for tracking the disease and judging outlook. They could also work as drug carriers or vaccine parts, turning a disease tool against itself. The review gathers what is known about exosome roles in how the leukemia starts and spreads. The authors frame them as both a window into the disease and a possible handle for treatment.
Catalog record
| CREATOR | Wandi Wang, Xiaofang Wu, Jiamian Zheng, Ran Yin, Yangqiu Li, Xiuli Wu, Ling Xu, Zhenyi Jin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |